艾普森生醫 | SCI期刊論文 | DNA 甲基化平台技術 | 定性/定量甲基化分析技術
SCI期刊論文
Lu CY, Tsai KF, Yen CJ, Hsieh CJ, Peng PJ, Huang SC, Chuang MR, Chu CJ. Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clin Exp Med. 2025 Mar 14;25(1):83-91.
Lu CY, Lin CP, Lee HL, Peng PJ, Huang SC, Chuang MR, Lin YJ. Epigenetic Perspectives and Their Prognostic Value in Early Recurrence After Hepatocellular Carcinoma Resection. Cancers (Basel). 2025 Feb 24;17(5):769-785.
Hsiao CY, Lu CY, Su HJ, Huang KW. Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma. Oncology. 2024 Mar 25;102(11):935–943.
Lu CY, Hsiao CY, Peng PJ, Huang SC, Chuang MR, Su HJ, Huang KW. DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers. 2023 Sep 7;15(18):4465-4481.
Lu CY, Chen SY, Lin CJ, Kan PY, Peng HL, Liu YC, Tsao CY, Chang WC, Yen CJ. Cell-free Methylation Markers with Diagnostic and Prognostic Potential in Hepatocellular Carcinoma. Oncotarget. 2017 Jan 24;8(4):6406- 6418.
Lu CY, Lin KY, Tien MT, Wu CT, Uen YH, Tseng TL. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma. Genes Chromosomes Cancer. 2013 July;52(7):636-643.
Wu CS, Lu YJ, Li HP, Hsueh C, Lu CY, Leu YW, Liu HP, Lin KH, Hui-Ming Huang T, Chang YS. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer. 2010 Jun 1;126(11):2542-52.
Lu YJ, Wu CS, Li HP, Liu HP, Lu CY, Leu YW, Wang CS, Chen LC, Lin KH, Chang YS. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer. Genes Chromosomes Cancer. 2010 May;49(5):412-24.
Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, and Chang YS. Aberrant DNA Methylation Profile and Frequent Methylation of KLK10 and OXGR1 Genes in Hepatocellular Carcinoma. Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68.
研討會論文
- Lu CY. Applications of Circulating Cell-free DNA Methylation Markers in Diagnosis and Prognosis of Liver Cancer. Exosomes and Liquid Biopsies ASIA, Poster No. ELBA3, Taipei, Taiwan. 2017.
- Lu CY, Tien MT, Wu CT and Tseng TL. A Genome-wide Approach to Identify Methylation-regulated MicroRNA in Cancer. Next Generation Dx Summit 2014, Poster No. 102, Washington DC, USA. 2014.
- Lu CY, Lin KY, Tien MT, Wu CT, Uen YH and Tseng TL. MiR-129-2 Methylation as an Early Diagnostic Marker in Hepatocellular Carcinoma. APASL (Asian Pacific Association for the Study of the Liver) Liver Week, Poster No. P102, Singapore. 2013.
- Lu CY, Lin KY, Tien MT, Wu CT Uen YH and Tseng TL. Early Diagnostic Methylation Marker in Hepatocellular Carcinoma. ITRI Medical Device and Biomedical Technology Forum, Taiwan. 2012.
- Lu CY, Tien MT, Wu CT Uen YH and Lin KY. Methylated miRNA Acts as a HCC Prognostic Marker. ITRI Medical Device and Biomedical Technology Forum, Taiwan. 2011.
-
Lu CY, Tien MT, Wu CT and Tseng TL. Identification of tumor suppressor miRNAs regulated by DNA methylation in hepatocellular carcinoma cells. ITRI Medical Device and Biomedical Technology Forum, Taiwan. 2010.